FOR PREVIEW ONLY (Print)

Howard M. Sandler, MD

Chair, Department of Radiation Oncology

Chair, Radiation Oncology

Professor, Radiation Oncology

Ronald H. Bloom Family Chair in Cancer Therapeutics

Cedars-Sinai Medical Center
8700 Beverly Blvd.
Los Angeles, CA 90048

Phone:

310-423-4204

Fax:

310-659-3332

2428 Santa Monica Blvd.
Santa Monica, CA

Phone:

310-828-0061

Fax:

310-829-2862

Howard M. Sandler, MD

Chair, Department of Radiation Oncology

Chair, Radiation Oncology

Professor, Radiation Oncology

Ronald H. Bloom Family Chair in Cancer Therapeutics

  • Radiation Oncology

Bladder Cancers

Brain Tumors

IMRT (Intensity-Modulated Radiation Therapy)

Prostate Cancers

Skin Cancers

Howard Sandler, MD, is principal investigator for a national Radiation Therapy Oncology Group study examining radiotherapy and chemotherapy for prostate cancer. He recently led a clinical trial grant funded by the National Institutes of Health to investigate novel radiation targeting strategies for prostate cancer. Sandler's studies also include evaluating the quality of life of prostate cancer patients following surgery and radiation therapy.

View NIH Biographical Sketch as a PDF

  • Medical School: University of Connecticut School of Medicine, 1985
  • Internship: St. Francis Hospital, 1986
  • Residency: Hospital of the University of Pennsylvania, 1989

View CV as a PDF

  • Program Chair, 2010 ASCO-ASTRO-SUO Genitourinary Cancer Symposium, 2008
  • Chairman, NRG Oncology/RTOG Genitourinary Cancer Committee, 1997
  • Chen RC, Chang P, Vetter RJ, Lukka H, Stokes WA, Sanda MG, Watkins-Bruner D, Reeve BB, Sandler HM. Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst. 2014;106(7).
  • Hamstra DA, Bae K, Hanks G, Shipley WU, Pan CC, Roach M 3rd, Lawton CA, Sandler HM. Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413. Cancer. 2015;121(6):844-852.
  • Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsy N, Saigal CS, Litwin MS, et al. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011;306(11):1205-1214.
  • Jones CU, Hunt D, McGowan DG, Amin MB, Chetner MP, Bruner DW, Liebenhaut MH, Husain SM, Rotman M, Souhami L, Sandler HM, et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med. 2011;365(2):107-118.
  • Sandler HM, Liu PY, Dunn RL, Khan DC, Tropper SE, Sanda MG, Mantz CA. Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study. Urology. 2010;75(5):1004-1008.
  • Pollack A, Bae K, Khor LY, Al-Saleem T, Hammond ME, Venkatesan V, Byhardt RW, Asbell SO, Shipley WU, Sandler HM. The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02. Clin Cancer Res. 2009;15(17):5478-5484.
  • Ray ME, Bae K, Hussain MH, Hanks GE, Shipley WU, Sandler HM. Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial. J Natl Cancer Inst. 2009;101(4):228-236.

Show moreShow less

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Howard M. Sandler, MD